» Articles » PMID: 15500445

Analysis of Normal and Mutant Iduronate-2-sulphatase Conformation

Overview
Journal Biochem J
Specialty Biochemistry
Date 2004 Oct 27
PMID 15500445
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian sulphatases (EC 3.1.6) are a family of enzymes that have a high degree of similarity in amino acid sequence, structure and catalytic mechanism. IDS (iduronate-2-sulphatase; EC 3.1.6.13) is a lysosomal exo-sulphatase that belongs to this protein family and is involved in the degradation of the glycosaminoglycans heparan sulphate and dermatan sulphate. An IDS deficiency causes the lysosomal storage disorder MPS II (mucopolysaccharidosis type II). To examine the structural alterations in heat-denatured and mutant IDS, a panel of four monoclonal antibodies was raised to the denatured protein and used as probes of protein conformation. The linear sequence epitope reactivity of a polyclonal antibody raised against the native protein and the monoclonal antibodies were defined and mapped to distinct regions on the IDS protein. The antigenicity of native IDS was higher in regions without glycosylation, but reactivity was not restricted to protein surface epitopes. One monoclonal epitope was relatively surface accessible and in close proximity to an N-linked glycosylation site, while three others required additional thermal energy to expose the epitopes. The monoclonal antibodies demonstrated the capacity to differentiate progressive structural changes in IDS and could be used to characterize the severity of MPS type II in patients based on variable denatured microstates.

Citing Articles

SAAMP 2.0: An algorithm to predict genotype-phenotype correlation of lysosomal storage diseases.

Ou L, Przybilla M, Whitley C Clin Genet. 2018; 93(5):1008-1014.

PMID: 29396849 PMC: 5899622. DOI: 10.1111/cge.13226.


Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases.

Saito S, Ohno K, Okuyama T, Sakuraba H PLoS One. 2016; 11(10):e0163964.

PMID: 27695081 PMC: 5047593. DOI: 10.1371/journal.pone.0163964.


A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome.

Chung Y, Sohn Y, Sohn J, Lee J, Chang M, Kwun Y Glycoconj J. 2014; 31(4):309-15.

PMID: 24781369 DOI: 10.1007/s10719-014-9523-0.


Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy.

Polito V, Abbondante S, Polishchuk R, Nusco E, Salvia R, Cosma M Hum Mol Genet. 2010; 19(24):4871-85.

PMID: 20876612 PMC: 2989894. DOI: 10.1093/hmg/ddq420.

References
1.
von Bulow R, Schmidt B, Dierks T, von Figura K, Uson I . Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis. J Mol Biol. 2000; 305(2):269-77. DOI: 10.1006/jmbi.2000.4297. View

2.
Korth C, Streit P, Oesch B . Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein. Methods Enzymol. 1999; 309:106-22. DOI: 10.1016/s0076-6879(99)09010-2. View

3.
Galperin M, Jedrzejas M . Conserved core structure and active site residues in alkaline phosphatase superfamily enzymes. Proteins. 2001; 45(4):318-24. DOI: 10.1002/prot.1152. View

4.
Borromeo V, Gaggioli D, Berrini A, Secchi C . Monoclonal antibodies as a probe for the unfolding of porcine growth hormone. J Immunol Methods. 2002; 272(1-2):107-15. DOI: 10.1016/s0022-1759(02)00433-7. View

5.
Kim C, Hwang H, Song S, Paik K, Kwon E, Moon K . Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations. Hum Mutat. 2003; 21(4):449-50. DOI: 10.1002/humu.9128. View